Haplotype Structures and Protein Levels of TGFB1 in HPV Infection and Cervical Lesion: A Case-Control Study

This study aimed to verify the role of <i>TGFB1</i> variants (c.–1638G>A, c.–1347C>T, c.29C>T, and c.74G>C) in HPV infection susceptibility and cervical lesions development, and their impact on TGFB1 cervical and plasma levels. <i>TGFB1</i> genotypes were assessed...

Full description

Bibliographic Details
Main Authors: Kleber Paiva Trugilo, Guilherme Cesar Martelossi Cebinelli, Érica Romão Pereira, Nádia Calvo Martins Okuyama, Fernando Cezar-dos-Santos, Eliza Pizarro Castilha, Tamires Flauzino, Valéria Bumiller-Bini Hoch, Maria Angelica Ehara Watanabe, Roberta Losi Guembarovski, Karen Brajão de Oliveira
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/1/84
_version_ 1797626148392271872
author Kleber Paiva Trugilo
Guilherme Cesar Martelossi Cebinelli
Érica Romão Pereira
Nádia Calvo Martins Okuyama
Fernando Cezar-dos-Santos
Eliza Pizarro Castilha
Tamires Flauzino
Valéria Bumiller-Bini Hoch
Maria Angelica Ehara Watanabe
Roberta Losi Guembarovski
Karen Brajão de Oliveira
author_facet Kleber Paiva Trugilo
Guilherme Cesar Martelossi Cebinelli
Érica Romão Pereira
Nádia Calvo Martins Okuyama
Fernando Cezar-dos-Santos
Eliza Pizarro Castilha
Tamires Flauzino
Valéria Bumiller-Bini Hoch
Maria Angelica Ehara Watanabe
Roberta Losi Guembarovski
Karen Brajão de Oliveira
author_sort Kleber Paiva Trugilo
collection DOAJ
description This study aimed to verify the role of <i>TGFB1</i> variants (c.–1638G>A, c.–1347C>T, c.29C>T, and c.74G>C) in HPV infection susceptibility and cervical lesions development, and their impact on TGFB1 cervical and plasma levels. <i>TGFB1</i> genotypes were assessed with PCR-RFLP and haplotypes were inferred for 190 HPV-uninfected and 161 HPV-infected women. TGFB1 levels were determined with immunofluorimetric assay. Case-control analyses were performed with logistic regression adjusted for possible confounders. Women carrying –1347TT or –1347CT+TT as well as those with 29CT, 29CC, or 29CT+CC were more likely to have HPV than –1347CC and 29TT carriers, respectively. Regarding haplotypes, the most frequent were *4 (GCTG) and *3 (GTCG). Women *4/*4 were less likely to have HPV than those with no *4 copy. Comparing the inheritance of *3 and *4, carriers of *3/*4 or *3/*3 were more susceptible to HPV than *4/*4. The TGFB1 plasma and cervical levels were higher in the infected patients. Plasma levels were also higher in infected women with low-grade lesions. HPV-infected patients carrying *3/Other and *3/Other+*3/*3 presented lower TGFB1 plasma levels than those with no copy of *3. TGFB1 variants could contribute to the comprehension of the TGFB1 role in HPV-caused cervical disease.
first_indexed 2024-03-11T10:06:22Z
format Article
id doaj.art-e884887ba40b4be59dbf79a303d93e4b
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-11T10:06:22Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-e884887ba40b4be59dbf79a303d93e4b2023-11-16T15:05:52ZengMDPI AGCells2073-44092022-12-011218410.3390/cells12010084Haplotype Structures and Protein Levels of TGFB1 in HPV Infection and Cervical Lesion: A Case-Control StudyKleber Paiva Trugilo0Guilherme Cesar Martelossi Cebinelli1Érica Romão Pereira2Nádia Calvo Martins Okuyama3Fernando Cezar-dos-Santos4Eliza Pizarro Castilha5Tamires Flauzino6Valéria Bumiller-Bini Hoch7Maria Angelica Ehara Watanabe8Roberta Losi Guembarovski9Karen Brajão de Oliveira10Laboratory of Molecular Genetics and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, BrazilLaboratory of Molecular Genetics and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, BrazilLaboratory of Molecular Genetics and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, BrazilLaboratory of Molecular Genetics and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, BrazilLaboratory of Molecular Genetics and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, BrazilLaboratory of Molecular Genetics and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, BrazilLaboratory of Research in Applied Immunology, State University of Londrina, Londrina 86057-970, PR, BrazilLaboratory of Human Molecular Genetics, Department of Genetics, Federal University of Paraná, Curitiba 80060-000, PR, BrazilLaboratory of Studies and Applications of DNA Polymorphisms and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, BrazilLaboratory of Mutagenesis and Oncogenetics, Department of Biological Sciences, State University of Londrina, Londrina 86057-970, PR, BrazilLaboratory of Molecular Genetics and Immunology, Department of Pathological Sciences, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, BrazilThis study aimed to verify the role of <i>TGFB1</i> variants (c.–1638G>A, c.–1347C>T, c.29C>T, and c.74G>C) in HPV infection susceptibility and cervical lesions development, and their impact on TGFB1 cervical and plasma levels. <i>TGFB1</i> genotypes were assessed with PCR-RFLP and haplotypes were inferred for 190 HPV-uninfected and 161 HPV-infected women. TGFB1 levels were determined with immunofluorimetric assay. Case-control analyses were performed with logistic regression adjusted for possible confounders. Women carrying –1347TT or –1347CT+TT as well as those with 29CT, 29CC, or 29CT+CC were more likely to have HPV than –1347CC and 29TT carriers, respectively. Regarding haplotypes, the most frequent were *4 (GCTG) and *3 (GTCG). Women *4/*4 were less likely to have HPV than those with no *4 copy. Comparing the inheritance of *3 and *4, carriers of *3/*4 or *3/*3 were more susceptible to HPV than *4/*4. The TGFB1 plasma and cervical levels were higher in the infected patients. Plasma levels were also higher in infected women with low-grade lesions. HPV-infected patients carrying *3/Other and *3/Other+*3/*3 presented lower TGFB1 plasma levels than those with no copy of *3. TGFB1 variants could contribute to the comprehension of the TGFB1 role in HPV-caused cervical disease.https://www.mdpi.com/2073-4409/12/1/84polymorphismrs1800468rs1800469rs1800470rs1800471
spellingShingle Kleber Paiva Trugilo
Guilherme Cesar Martelossi Cebinelli
Érica Romão Pereira
Nádia Calvo Martins Okuyama
Fernando Cezar-dos-Santos
Eliza Pizarro Castilha
Tamires Flauzino
Valéria Bumiller-Bini Hoch
Maria Angelica Ehara Watanabe
Roberta Losi Guembarovski
Karen Brajão de Oliveira
Haplotype Structures and Protein Levels of TGFB1 in HPV Infection and Cervical Lesion: A Case-Control Study
Cells
polymorphism
rs1800468
rs1800469
rs1800470
rs1800471
title Haplotype Structures and Protein Levels of TGFB1 in HPV Infection and Cervical Lesion: A Case-Control Study
title_full Haplotype Structures and Protein Levels of TGFB1 in HPV Infection and Cervical Lesion: A Case-Control Study
title_fullStr Haplotype Structures and Protein Levels of TGFB1 in HPV Infection and Cervical Lesion: A Case-Control Study
title_full_unstemmed Haplotype Structures and Protein Levels of TGFB1 in HPV Infection and Cervical Lesion: A Case-Control Study
title_short Haplotype Structures and Protein Levels of TGFB1 in HPV Infection and Cervical Lesion: A Case-Control Study
title_sort haplotype structures and protein levels of tgfb1 in hpv infection and cervical lesion a case control study
topic polymorphism
rs1800468
rs1800469
rs1800470
rs1800471
url https://www.mdpi.com/2073-4409/12/1/84
work_keys_str_mv AT kleberpaivatrugilo haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy
AT guilhermecesarmartelossicebinelli haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy
AT ericaromaopereira haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy
AT nadiacalvomartinsokuyama haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy
AT fernandocezardossantos haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy
AT elizapizarrocastilha haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy
AT tamiresflauzino haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy
AT valeriabumillerbinihoch haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy
AT mariaangelicaeharawatanabe haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy
AT robertalosiguembarovski haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy
AT karenbrajaodeoliveira haplotypestructuresandproteinlevelsoftgfb1inhpvinfectionandcervicallesionacasecontrolstudy